Ahdieh; Harry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ahdieh; Harry.The latest application filed is for "method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment".

Company Profile

0.4.6

Ahdieh; Harry - Lincoln University PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment Grant 11,389,443 - Ahdieh July 19, 2	2022-07-19
Method Of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions And Instruction On Dosing For Renal Impairment App 20180098985 - Ahdieh; Harry	2018-04-12
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment Grant 9,789,103 - Ahdieh October 17, 2	2017-10-17
Method Of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions And Instruction On Dosing For Renal Impairment App 20140329847 - Ahdieh; Harry	2014-11-06
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment Grant 8,808,737 - Ahdieh August 19, 2	2014-08-19
Method Of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions And Instruction On Dosing For Renal Impairment App 20100151027 - Ahdieh; Harry	2010-06-17
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol App 20090124650 - Ahdieh; Harry	2009-05-14
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment App 20080318993 - Ahdieh; Harry	2008-12-25
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment App 20080318994 - Ahdieh; Harry	2008-12-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.